OBJECTIVES: To examine the effect of race/ethnicity and fear characteristics on the initiation and maintenance of digital rectal examination (DRE) screening. METHODS: A total of 533 men from Brooklyn, New York, aged 45-70 years, were classified into 4 race/ethnic groups: U.S.-born whites, U.S.-born African-American, Jamaican, and Trinidadian/Tobagonian. The participants recorded the number of DREs in the past 10 years. The demographics and structural variables and prostate cancer worry and screening fear were measured using validated tools. RESULTS: Overall, 30% of subjects reported never having a DRE, and 24% reported annual DREs. African-American, Jamaican, and Trinidadian/Tobagonian men had greater prostate cancer worry and screening fear scores than did the white men (all P < .05). African-American, Jamaican, and Trinidadian/Tobagonian men were less likely to maintain annual DREs than white men (odds ratio 0.17, 0.26, and 0.16, respectively, all P < .05). The men with low screening fear were more likely to have had an initial DRE (OR 2.3, P < .05 vs high screening fear) but were no more or less likely to undergo annual DREs. Having a regular physician, comprehensive physician discussion, and annual visits were also associated with undergoing DREs. CONCLUSIONS: We identified several ethnically varying barriers and facilitators to DRE screening. African-American and African-Caribbean men undergo DRE less often and have greater prostate cancer worry and screening fear scores than did white men. Screening fear predicts the likelihood of undergoing an initial, but not annual, DRE screening. Access to a physician and annual visits facilitate DRE screening. Interventions that include both culturally sensitive education and patient navigation and considered whether patients should be initiating or maintaining screening might facilitate guideline-consistent screening.
OBJECTIVES: To examine the effect of race/ethnicity and fear characteristics on the initiation and maintenance of digital rectal examination (DRE) screening. METHODS: A total of 533 men from Brooklyn, New York, aged 45-70 years, were classified into 4 race/ethnic groups: U.S.-born whites, U.S.-born African-American, Jamaican, and Trinidadian/Tobagonian. The participants recorded the number of DREs in the past 10 years. The demographics and structural variables and prostate cancer worry and screening fear were measured using validated tools. RESULTS: Overall, 30% of subjects reported never having a DRE, and 24% reported annual DREs. African-American, Jamaican, and Trinidadian/Tobagonian men had greater prostate cancer worry and screening fear scores than did the white men (all P < .05). African-American, Jamaican, and Trinidadian/Tobagonian men were less likely to maintain annual DREs than white men (odds ratio 0.17, 0.26, and 0.16, respectively, all P < .05). The men with low screening fear were more likely to have had an initial DRE (OR 2.3, P < .05 vs high screening fear) but were no more or less likely to undergo annual DREs. Having a regular physician, comprehensive physician discussion, and annual visits were also associated with undergoing DREs. CONCLUSIONS: We identified several ethnically varying barriers and facilitators to DRE screening. African-American and African-Caribbean men undergo DRE less often and have greater prostate cancer worry and screening fear scores than did white men. Screening fear predicts the likelihood of undergoing an initial, but not annual, DRE screening. Access to a physician and annual visits facilitate DRE screening. Interventions that include both culturally sensitive education and patient navigation and considered whether patients should be initiating or maintaining screening might facilitate guideline-consistent screening.
Authors: Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen Journal: N Engl J Med Date: 2009-03-18 Impact factor: 91.245
Authors: Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg Journal: N Engl J Med Date: 2009-03-18 Impact factor: 91.245
Authors: Kirsten L Greene; Peter C Albertsen; Richard J Babaian; H Ballentine Carter; Peter H Gann; Misop Han; Deborah Ann Kuban; A Oliver Sartor; Janet L Stanford; Anthony Zietman; Peter Carroll Journal: J Urol Date: 2009-09-24 Impact factor: 7.450
Authors: Nathan S Consedine; Amy H Morgenstern; Elizabeth Kudadjie-Gyamfi; Carol Magai; Alfred I Neugut Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-02 Impact factor: 4.254
Authors: Monique J Roobol; Fritz H Schröder; E David Crawford; Stephen J Freedland; A Oliver Sartor; Neil Fleshner; Gerald L Andriole Journal: J Urol Date: 2009-09-16 Impact factor: 7.450
Authors: Adrienne A Phillips; Judith S Jacobson; Carol Magai; Nathan Consedine; Nathalie C Horowicz-Mehler; Alfred I Neugut Journal: Cancer Invest Date: 2007-09 Impact factor: 2.176
Authors: Alan G Nyitray; Joseph T Hicks; Lu-Yu Hwang; Sarah Baraniuk; Margaret White; Stefanos Millas; Nkechi Onwuka; Xiaotao Zhang; Eric L Brown; Michael W Ross; Elizabeth Y Chiao Journal: Sex Transm Infect Date: 2017-08-23 Impact factor: 3.519
Authors: Erica G Bromley; Folasade P May; Lisa Federer; Brennan M R Spiegel; Martijn G H van Oijen Journal: Prev Med Date: 2014-12-04 Impact factor: 4.018
Authors: Laura J James; Germaine Wong; Jonathan C Craig; Camilla S Hanson; Angela Ju; Kirsten Howard; Tim Usherwood; Howard Lau; Allison Tong Journal: PLoS One Date: 2017-11-28 Impact factor: 3.240
Authors: David Eldred-Evans; Henry Tam; Heminder Sokhi; Anwar R Padhani; Mathias Winkler; Hashim U Ahmed Journal: Nat Rev Urol Date: 2020-07-21 Impact factor: 14.432
Authors: Charlotte Vrinten; Cornelia H M van Jaarsveld; Jo Waller; Christian von Wagner; Jane Wardle Journal: BMC Cancer Date: 2014-08-16 Impact factor: 4.430